Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
The Toxicokinetic Profile of Dex40-GTMAC3-a Novel Polysaccharide Candidate for Reversal of Unfractionated Heparin.

Frontiers in pharmacology

Sokolowska E, Kalaska B, Kaminski K, Lewandowska A, Blazejczyk A, Wietrzyk J, Kasacka I, Szczubialka K, Pawlak D, Nowakowska M, Mogielnicki A.
PMID: 27014072
Front Pharmacol. 2016 Mar 17;7:60. doi: 10.3389/fphar.2016.00060. eCollection 2016.

Though protamine sulfate is the only approved antidote of unfractionated heparin (UFH), yet may produce life threatening side effects such as systemic hypotension, catastrophic pulmonary vasoconstriction or allergic reactions. We have described 40 kDa dextrans (Dex40) substituted with glycidyltrimethylammonium...

Cite
Sokolowska E, Kalaska B, Kaminski K, et al. The Toxicokinetic Profile of Dex40-GTMAC3-a Novel Polysaccharide Candidate for Reversal of Unfractionated Heparin. Front Pharmacol. 2016;7:60doi: 10.3389/fphar.2016.00060.
Sokolowska, E., Kalaska, B., Kaminski, K., Lewandowska, A., Blazejczyk, A., Wietrzyk, J., Kasacka, I., Szczubialka, K., Pawlak, D., Nowakowska, M., & Mogielnicki, A. (2016). The Toxicokinetic Profile of Dex40-GTMAC3-a Novel Polysaccharide Candidate for Reversal of Unfractionated Heparin. Frontiers in pharmacology, 760. https://doi.org/10.3389/fphar.2016.00060
Sokolowska, Emilia, et al. "The Toxicokinetic Profile of Dex40-GTMAC3-a Novel Polysaccharide Candidate for Reversal of Unfractionated Heparin." Frontiers in pharmacology vol. 7 (2016): 60. doi: https://doi.org/10.3389/fphar.2016.00060
Sokolowska E, Kalaska B, Kaminski K, Lewandowska A, Blazejczyk A, Wietrzyk J, Kasacka I, Szczubialka K, Pawlak D, Nowakowska M, Mogielnicki A. The Toxicokinetic Profile of Dex40-GTMAC3-a Novel Polysaccharide Candidate for Reversal of Unfractionated Heparin. Front Pharmacol. 2016 Mar 17;7:60. doi: 10.3389/fphar.2016.00060. eCollection 2016. PMID: 27014072; PMCID: PMC4794501.
Copy Download .nbib Format: NLM
Morphometric Analysis of One-Component Polyurethane Foams Applicable in the Building Sector via X-ray Computed Microtomography.

Materials (Basel, Switzerland)

Blazejczyk A.
PMID: 30217098
Materials (Basel). 2018 Sep 13;11(9). doi: 10.3390/ma11091717.

A detailed morphometric analysis of one-component polyurethane (PU) expanding foams, with densities of 26 and 28 kg/m³ ('SUMMER' and 'WINTER' product versions), was conducted to evaluate the topology of the foam cells and to discover processing-to-structure relationships. The microstructural...

Cite
Blazejczyk A. Morphometric Analysis of One-Component Polyurethane Foams Applicable in the Building Sector via X-ray Computed Microtomography. Materials (Basel). 2018;11(9)doi: 10.3390/ma11091717.
Blazejczyk, A. (2018). Morphometric Analysis of One-Component Polyurethane Foams Applicable in the Building Sector via X-ray Computed Microtomography. Materials (Basel, Switzerland), 11(9), . https://doi.org/10.3390/ma11091717
Blazejczyk, Aurelia. "Morphometric Analysis of One-Component Polyurethane Foams Applicable in the Building Sector via X-ray Computed Microtomography." Materials (Basel, Switzerland) vol. 11,9 (2018). doi: https://doi.org/10.3390/ma11091717
Blazejczyk A. Morphometric Analysis of One-Component Polyurethane Foams Applicable in the Building Sector via X-ray Computed Microtomography. Materials (Basel). 2018 Sep 13;11(9). doi: 10.3390/ma11091717. PMID: 30217098; PMCID: PMC6163629.
Copy Download .nbib Format: NLM
Change in Conductive-Radiative Heat Transfer Mechanism Forced by Graphite Microfiller in Expanded Polystyrene Thermal Insulation-Experimental and Simulated Investigations.

Materials (Basel, Switzerland)

Blazejczyk A, Jastrzebski C, Wierzbicki M.
PMID: 32526870
Materials (Basel). 2020 Jun 09;13(11). doi: 10.3390/ma13112626.

This article introduces an innovative approach to the investigation of the conductive-radiative heat transfer mechanism in expanded polystyrene (EPS) thermal insulation at negligible convection. Closed-cell EPS foam (bulk density 14-17 kg·m

Cite
Blazejczyk A, Jastrzebski C, Wierzbicki M. Change in Conductive-Radiative Heat Transfer Mechanism Forced by Graphite Microfiller in Expanded Polystyrene Thermal Insulation-Experimental and Simulated Investigations. Materials (Basel). 2020;13(11)doi: 10.3390/ma13112626.
Blazejczyk, A., Jastrzebski, C., & Wierzbicki, M. (2020). Change in Conductive-Radiative Heat Transfer Mechanism Forced by Graphite Microfiller in Expanded Polystyrene Thermal Insulation-Experimental and Simulated Investigations. Materials (Basel, Switzerland), 13(11), . https://doi.org/10.3390/ma13112626
Blazejczyk, Aurelia, et al. "Change in Conductive-Radiative Heat Transfer Mechanism Forced by Graphite Microfiller in Expanded Polystyrene Thermal Insulation-Experimental and Simulated Investigations." Materials (Basel, Switzerland) vol. 13,11 (2020). doi: https://doi.org/10.3390/ma13112626
Blazejczyk A, Jastrzebski C, Wierzbicki M. Change in Conductive-Radiative Heat Transfer Mechanism Forced by Graphite Microfiller in Expanded Polystyrene Thermal Insulation-Experimental and Simulated Investigations. Materials (Basel). 2020 Jun 09;13(11). doi: 10.3390/ma13112626. PMID: 32526870; PMCID: PMC7321605.
Copy Download .nbib Format: NLM
Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network.

Dermatology (Basel, Switzerland)

Blazejak C, Stranzenbach R, Gosman J, Gambichler T, Wehkamp U, Stendel S, Klemke CD, Wobser M, Olk J, Nicolay JP, Weyermann M, Stadler R, Assaf C.
PMID: 34474414
Dermatology. 2021 Sep 02;1-9. doi: 10.1159/000517830. Epub 2021 Sep 02.

BACKGROUND: Gemcitabine is an effective single-agent chemotherapy used in advanced stages of cutaneous T-cell lymphoma (CTCL). However, gemcitabine used in the current standard regimen is frequently associated with adverse events (AE), such as an increased risk for myelosuppression and...

Cite
Blazejak C, Stranzenbach R, Gosman J, et al. Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network. Dermatology. 2021;1-9doi: 10.1159/000517830.
Blazejak, C., Stranzenbach, R., Gosman, J., Gambichler, T., Wehkamp, U., Stendel, S., Klemke, C. D., Wobser, M., Olk, J., Nicolay, J. P., Weyermann, M., Stadler, R., & Assaf, C. (2021). Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network. Dermatology (Basel, Switzerland), 1-9. https://doi.org/10.1159/000517830
Blazejak, Christoph, et al. "Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network." Dermatology (Basel, Switzerland) vol. (2021): 1-9. doi: https://doi.org/10.1159/000517830
Blazejak C, Stranzenbach R, Gosman J, Gambichler T, Wehkamp U, Stendel S, Klemke CD, Wobser M, Olk J, Nicolay JP, Weyermann M, Stadler R, Assaf C. Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network. Dermatology. 2021 Sep 02;1-9. doi: 10.1159/000517830. Epub 2021 Sep 02. PMID: 34474414.
Copy Download .nbib Format: NLM
Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network.

Dermatology (Basel, Switzerland)

Blazejak C, Stranzenbach R, Gosman J, Gambichler T, Wehkamp U, Stendel S, Klemke CD, Wobser M, Olk J, Nicolay JP, Weyermann M, Stadler R, Assaf C.
PMID: 34474414
Dermatology. 2021 Sep 02;1-9. doi: 10.1159/000517830. Epub 2021 Sep 02.

BACKGROUND: Gemcitabine is an effective single-agent chemotherapy used in advanced stages of cutaneous T-cell lymphoma (CTCL). However, gemcitabine used in the current standard regimen is frequently associated with adverse events (AE), such as an increased risk for myelosuppression and...

Cite
Blazejak C, Stranzenbach R, Gosman J, et al. Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network. Dermatology. 2021;1-9doi: 10.1159/000517830.
Blazejak, C., Stranzenbach, R., Gosman, J., Gambichler, T., Wehkamp, U., Stendel, S., Klemke, C. D., Wobser, M., Olk, J., Nicolay, J. P., Weyermann, M., Stadler, R., & Assaf, C. (2021). Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network. Dermatology (Basel, Switzerland), 1-9. https://doi.org/10.1159/000517830
Blazejak, Christoph, et al. "Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network." Dermatology (Basel, Switzerland) vol. (2021): 1-9. doi: https://doi.org/10.1159/000517830
Blazejak C, Stranzenbach R, Gosman J, Gambichler T, Wehkamp U, Stendel S, Klemke CD, Wobser M, Olk J, Nicolay JP, Weyermann M, Stadler R, Assaf C. Clinical Outcomes of Advanced-Stage Cutaneous Lymphoma under Low-Dose Gemcitabine Treatment: Real-Life Data from the German Cutaneous Lymphoma Network. Dermatology. 2021 Sep 02;1-9. doi: 10.1159/000517830. Epub 2021 Sep 02. PMID: 34474414.
Copy Download .nbib Format: NLM
Modification of internal hernia classification system after laparoscopic Roux-en-Y bariatric surgery.

Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques

Karcz WK, Zhou C, Daoud M, Gong Z, Blazejczyk K, Keck T, Matlok M, Zimmermann M, Kuehling A, Fink J.
PMID: 26240619
Wideochir Inne Tech Maloinwazyjne. 2015 Jul;10(2):197-204. doi: 10.5114/wiitm.2015.52160. Epub 2015 Jun 10.

INTRODUCTION: The occurrence of internal hernia is not an uncommon late complication following the laparoscopic bariatric Roux-en-Y gastric bypass procedure. In some instances, it can be life threatening if not treated in a timely manner. Although there are numerous...

Cite
Karcz WK, Zhou C, Daoud M, et al. Modification of internal hernia classification system after laparoscopic Roux-en-Y bariatric surgery. Wideochir Inne Tech Maloinwazyjne. 2015;10(2):197-204doi: 10.5114/wiitm.2015.52160.
Karcz, W. K., Zhou, C., Daoud, M., Gong, Z., Blazejczyk, K., Keck, T., Matlok, M., Zimmermann, M., Kuehling, A., & Fink, J. (2015). Modification of internal hernia classification system after laparoscopic Roux-en-Y bariatric surgery. Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques, 10(2), 197-204. https://doi.org/10.5114/wiitm.2015.52160
Karcz, W Konrad, et al. "Modification of internal hernia classification system after laparoscopic Roux-en-Y bariatric surgery." Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques vol. 10,2 (2015): 197-204. doi: https://doi.org/10.5114/wiitm.2015.52160
Karcz WK, Zhou C, Daoud M, Gong Z, Blazejczyk K, Keck T, Matlok M, Zimmermann M, Kuehling A, Fink J. Modification of internal hernia classification system after laparoscopic Roux-en-Y bariatric surgery. Wideochir Inne Tech Maloinwazyjne. 2015 Jul;10(2):197-204. doi: 10.5114/wiitm.2015.52160. Epub 2015 Jun 10. PMID: 26240619; PMCID: PMC4520845.
Copy Download .nbib Format: NLM
GSK3α and GSK3β Phosphorylate Arc and Regulate its Degradation.

Frontiers in molecular neuroscience

Gozdz A, Nikolaienko O, Urbanska M, Cymerman IA, Sitkiewicz E, Blazejczyk M, Dadlez M, Bramham CR, Jaworski J.
PMID: 28670266
Front Mol Neurosci. 2017 Jun 16;10:192. doi: 10.3389/fnmol.2017.00192. eCollection 2017.

The selective and neuronal activity-dependent degradation of synaptic proteins appears to be crucial for long-term synaptic plasticity. One such protein is activity-regulated cytoskeleton-associated protein (Arc), which regulates the synaptic content of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPAR), excitatory synapse strength and...

Cite
Gozdz A, Nikolaienko O, Urbanska M, et al. GSK3α and GSK3β Phosphorylate Arc and Regulate its Degradation. Front Mol Neurosci. 2017;10:192doi: 10.3389/fnmol.2017.00192.
Gozdz, A., Nikolaienko, O., Urbanska, M., Cymerman, I. A., Sitkiewicz, E., Blazejczyk, M., Dadlez, M., Bramham, C. R., & Jaworski, J. (2017). GSK3α and GSK3β Phosphorylate Arc and Regulate its Degradation. Frontiers in molecular neuroscience, 10192. https://doi.org/10.3389/fnmol.2017.00192
Gozdz, Agata, et al. "GSK3α and GSK3β Phosphorylate Arc and Regulate its Degradation." Frontiers in molecular neuroscience vol. 10 (2017): 192. doi: https://doi.org/10.3389/fnmol.2017.00192
Gozdz A, Nikolaienko O, Urbanska M, Cymerman IA, Sitkiewicz E, Blazejczyk M, Dadlez M, Bramham CR, Jaworski J. GSK3α and GSK3β Phosphorylate Arc and Regulate its Degradation. Front Mol Neurosci. 2017 Jun 16;10:192. doi: 10.3389/fnmol.2017.00192. eCollection 2017. PMID: 28670266; PMCID: PMC5472658.
Copy Download .nbib Format: NLM
Answer to letter: Factors that can alter the melatonin circadian rhythm, by Yvan Touitou, Michael H. Smolensky and Alain Reinberg.

Chronobiology international

Wieczorek J, Blazejczyk K, Morita T.
PMID: 27715323
Chronobiol Int. 2016;33(9):1131-1135. doi: 10.1080/07420528.2016.1215955. Epub 2016 Aug 12.

No abstract available.

Cite
Wieczorek J, Blazejczyk K, Morita T. Answer to letter: Factors that can alter the melatonin circadian rhythm, by Yvan Touitou, Michael H. Smolensky and Alain Reinberg. Chronobiol Int. 2016;33(9):1131-1135doi: 10.1080/07420528.2016.1215955.
Wieczorek, J., Blazejczyk, K., & Morita, T. (2016). Answer to letter: Factors that can alter the melatonin circadian rhythm, by Yvan Touitou, Michael H. Smolensky and Alain Reinberg. Chronobiology international, 33(9), 1131-1135. https://doi.org/10.1080/07420528.2016.1215955
Wieczorek, Joanna, et al. "Answer to letter: Factors that can alter the melatonin circadian rhythm, by Yvan Touitou, Michael H. Smolensky and Alain Reinberg." Chronobiology international vol. 33,9 (2016): 1131-1135. doi: https://doi.org/10.1080/07420528.2016.1215955
Wieczorek J, Blazejczyk K, Morita T. Answer to letter: Factors that can alter the melatonin circadian rhythm, by Yvan Touitou, Michael H. Smolensky and Alain Reinberg. Chronobiol Int. 2016;33(9):1131-1135. doi: 10.1080/07420528.2016.1215955. Epub 2016 Aug 12. PMID: 27715323.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries